Matt Outten MBA, ALM, CPC
Chief Executive Officer at QED Therapeutics Oncology and Chief Commercial Officer at BridgeBio
BridgeBio•San Francisco Bay Area, United States
View LinkedIn ProfileExecutive Overview
I possess a proven track record in large and mid-size pharma and start-up biotechs, developing pre-commercial assets, launching products, driving sales, and gaining preferred coverage. I have worked across a wide range of disease states with a focus in oncology and rare diseases. Further, as an integral member of the executive team, I have conducted investor relations calls, performed due diligence for mergers / acquisitions, and managed co-promotion efforts. My greatest strengths lie in utilizing influence to garner buy-in from internal / external stakeholders, manage commercial strategy, develop long range strategic plans for both pre and post launch, and utilizing available resources to streamline operations, improve sales, and increase product access. I also possess experience in operations management, P&L accountability, Gross-to-Net management, and multimillion-dollar budget management. My reputation as an empowering leader has allowed me to hire, train, manage, develop, evaluate, and retain large teams of top-performing sales, marketing, and regional and national payer team members with full accountability to the organization’s goals. Core Competencies: ✔ Leading Marketing Teams through multiple launches ✔ Driving Sales Teams ✔ New Product and Indication Launch ✔ In-Line / Payer Marketing Strategies ✔ Rebate & Pricing Structuring / Negotiations ✔ Patient Assistance Program Creation ✔ Strategic Alliances / Co-Promotions ✔ Specialty Pharmacy / Distributor Network Formation ✔ Mergers / Acquisitions / Due Diligence ✔ Investor Relations ✔ Gross-to-Net Management ✔ P&L Accountability / Budget Administration ✔ Pipeline Strategy Development ✔ Personnel Recruitment / Management / Development ✔ Pharmacoeconomic Modeling
Career Timeline
- BridgeBioCurrentFeb 2019–Present· 7 yrs 8 mos
- Chief Executive Officer, QED Therapeutics, Oncology, Chief Commercial Officer, BridgeBioCurrentFeb 2019–Present
- Jul 2018–Feb 2019· 7 mos
- Chief Commercial OfficerJul 2018–Feb 2019
- 2013–Jul 2018· 5 yrs 6 mos
- Vice President of Marketing and Market Access2015–Jul 2018
- Vice President Commercial Operations / Interim CCO2014–2014
- Head of Market Access and Commercial Liaison2014–2015
- Executive Director Market Access / Senior Director Market Access2013–2014
- Jul 2008–Feb 2013· 4 yrs 7 mos
- Director Managed MarketsJun 2010–Feb 2013
- Associate Director of Reimbursement Strategy and National AccountsJul 2008–Jun 2010
- 2004–2008· 4 yrs
- US Managed Markets Senior Product Manager - Virology, Oncology, CNS, and New Product Development2007–2008
- US Managed Markets Product Manager Virology and Oncology2006–2007
- US Marketing Product Manager Virology2005–2006
- Virology Biologic Specialty Sales Representative2004–2005
- 2001–2004· 3 yrs
- Neurohealth Specialty Sales Representative2002–2004
- Pharmaceutical Sales Representative / Field Trainer2001–2002
Education
BA
Psychology
Hamilton CollegeMBA
Management
University of DelawareMaster of Liberal Arts in Extension Studies
Field: International Relations.
Harvard University